Skip to main content
SpringerLink
Log in

Strahlentherapie im Alter

Welche Besonderheiten sind zu berücksichtigen?

Radiation therapy in the elderly

Which characteristics must be considered?

  • Fokus
  • Published:
Forum Aims and scope

Zusammenfassung

Neben Operation und Chemotherapie stellt die Strahlentherapie eine wichtige Säule in der Tumortherapie dar. Mehr als zwei Drittel aller Krebspatienten werden auch radioonkologisch behandelt. Durch die rasante technologische Entwicklung einerseits und die Kombination von Strahlentherapie mit radiosensibilisierenden Substanzen andererseits hat die Effektivität der Strahlenbehandlung deutlich zugenommen, während die akuten und späten Nebenwirkungen seltener geworden sind. Dennoch zeigen insbesondere ältere Patienten eine gewisse Empfindlichkeit bei Radio- oder Radio-Chemo-Therapie. Im vorliegenden Beitrag werden das breite Spektrum der Indikationen für eine Strahlentherapie bei älteren Patienten und deren Besonderheiten diskutiert.

Abstract

In addition to surgery and chemotherapy, radiation therapy is an important component in the therapy of tumors. More than two thirds of cancer patients receive treated radiation oncology treatment. Due to the rapid technological development and the combination of radiation therapy with radiosensitizing substances, the effectiveness of radiation treatment has greatly increased whereas the acute and delayed side effects have become less frequent. Nevertheless, there is a certain degree of sensitivity to radiotherapy or chemoradiotherapy, especially in elderly patients. In this article the broad spectrum of indications for radiation therapy in elderly patients and their characteristics will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Geinitz H, Liesenfeld S, Zimmermann F et al (2003) Strahlentherapie im Alter: Indikationen, Effektivität und Verträglichkeit. Dtsch Arztebl 100(46):A3010–A3021

    Google Scholar 

  2. Lohmann M, Walenda G, Hemeda H et al (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 7(5):e37839

    Article  PubMed  CAS  Google Scholar 

  3. Andratschke N, Zimmermann F, Boehm E et al (2011) Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. Radiother Oncol 101(2):245–249

    Article  PubMed  Google Scholar 

  4. Duncker-Rohr V, Nestle U, Momm F et al (2013) Stereotactic ablative radiotherapy for small lung tumors with a moderate dose. Favorable results and low toxicity. Strahlenther Onkol 189(1):33–40

    Article  PubMed  CAS  Google Scholar 

  5. Wisnivesky JP, Halm E, Bonomi M et al (2010) Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med 181(3):264–269

    Article  PubMed  Google Scholar 

  6. Wisnivesky JP, Halm EA, Bonomi M et al (2012) Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer 118(18):4478–4485

    Article  PubMed  Google Scholar 

  7. Park CH, Bonomi M, Cesaretti J et al (2011) Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys 81(3):706–711

    Article  PubMed  Google Scholar 

  8. Lee JH, Wu HG, Kim HJ et al (2012) Influence of comorbidities on the efficacy of radiotherapy with or without chemotherapy in elderly stage III non-small cell lung cancer patients. Cancer Res Treat 44(4):242–250

    Article  PubMed  Google Scholar 

  9. Kharofa J, Gore E (2013) Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation. Clin Lung Cancer doi:pii:S1525-7304(12)00256-2. 10.1016/j.cllc.2012.10.005 (E-pub ahead of print)

  10. AWMF (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. Registernummer 043-022OL. http://www.awmf.org/uploads/tx_szleitlinien/043-022OLl_S3_Prostatakarzinom_2011.pdf

  11. Ghadjar P, Jackson A, Spratt DE et al (2013) Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity. Eur Urol doi:pii: S0302-2838(13)00113-9. 10.1016/j.eururo.2013.02.001 (E-pub ahead of print)

  12. Resnick MJ, Koyama T, Fan KH et al (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368(5):436–445

    Article  PubMed  CAS  Google Scholar 

  13. AWMF (2012) Interdisziplinäre S3-Leitlinien für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. AWMF-Register-Nummer: 032-045OL. http://www.awmf.org/uploads/tx_szleitlinien/032-045OL_l_S3__Brustkrebs_Mammakarzinom_Diagnostik_Therapie_Nachsorge_2012-07.pdf

  14. Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25(22):3259–3265

    Article  PubMed  Google Scholar 

  15. Early Breast Cancer Trialists‘ Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716

    Article  Google Scholar 

  16. Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013) Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol 189(3):193–196

    Article  PubMed  CAS  Google Scholar 

  17. Combs SE, Adeberg S, Dittmar JO et al (2012) Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol (E-pub ahead of print)

  18. Nieder C, Grosu AL, Spanne O et al (2012) Brain metastases in patients under 50 years of age: retrospective analysis. Clin Exp Metastasis 29(8):949–956

    Article  PubMed  Google Scholar 

  19. Wick W, Platten M, Meisner C et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707–715

    Article  PubMed  CAS  Google Scholar 

  20. Efstathiou JA, Spiegel DY, Shipley WU et al (2012) Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol 61(4):705–711

    Article  PubMed  Google Scholar 

  21. James ND, Hussain SA, Hall E et al (2012) Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med 366(16):1477–1488

    Article  PubMed  CAS  Google Scholar 

  22. Weiss C, Rödel C (2012) Urological cancer: chemoradiation superior in muscle-invasive bladder cancer. Nat Rev Clin Oncol 9(7):374–375

    Article  PubMed  Google Scholar 

  23. Hsieh CH, Chung SD, Chan PH et al (2011) Intensity modulated radiotherapy for elderly bladder cancer patients. Radiat Oncol 6:75

    Article  PubMed  Google Scholar 

  24. Howell DD, James JL, Hartsell WF et al (2013) Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer 119(4):888–896

    Article  PubMed  Google Scholar 

  25. Seegenschmiedt MH, Micke O, Willich N (2004) Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectives. Strahlenther Onkol 180(11):718–730

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Deutschland

    A.-L. Grosu & K. Henne

Authors
  1. A.-L. Grosu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Henne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A.-L. Grosu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grosu, AL., Henne, K. Strahlentherapie im Alter. Forum 28, 170–175 (2013). https://doi.org/10.1007/s12312-013-0942-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12312-013-0942-9

Schlüsselwörter

Keywords

Search

Navigation